期刊文献+

Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques 被引量:24

Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques
下载PDF
导出
摘要 Hepatocellular carcinoma(HCC)is one of the most common malignant diseases worldwide.While curative therapies,including resection,liver transplantation,and percutaneous ablation(percutaneous ethanol injection and radiofrequency ablation),are applicable for only a portion of the HCC population,transcatheter arterial chemoembolization(TACE)has been recognized as an effective palliative treatment option for patients with advanced HCC.TACE is also used even for single HCCs in which it is difficult to perform surgical resection or locoregional treatment due to systemic co-morbidities or anatomical problems.TACE has become widely adopted in the treatment of HCC.By using computed tomography-angiography,TACE is capable of performing diagnosis and treatment at the same time.Furthermore,TACE plays an important role in the multidisciplinary treatment for HCC when combined with other treatment.In this review,we first discuss the history of TACE,and then review the previous findings about techniques of achieving a locoregional treatment effect(liver infarction treatment,e.g.,ultra-selective TACE,balloon-occluded TACE),and the use of TACE as a drugdelivery system for anti-cancer agents(palliative,e.g.,platinum complex agents,drug-eluting beads)for multiple lesions. Hepatocellular carcinoma(HCC)is one of the most common malignant diseases worldwide.While curative therapies,including resection,liver transplantation,and percutaneous ablation(percutaneous ethanol injection and radiofrequency ablation),are applicable for only a portion of the HCC population,transcatheter arterial chemoembolization(TACE)has been recognized as an effective palliative treatment option for patients with advanced HCC.TACE is also used even for single HCCs in which it is difficult to perform surgical resection or locoregional treatment due to systemic co-morbidities or anatomical problems.TACE has become widely adopted in the treatment of HCC.By using computed tomography-angiography,TACE is capable of performing diagnosis and treatment at the same time.Furthermore,TACE plays an important role in the multidisciplinary treatment for HCC when combined with other treatment.In this review,we first discuss the history of TACE,and then review the previous findings about techniques of achieving a locoregional treatment effect(liver infarction treatment,e.g.,ultra-selective TACE,balloon-occluded TACE),and the use of TACE as a drugdelivery system for anti-cancer agents(palliative,e.g.,platinum complex agents,drug-eluting beads)for multiple lesions.
出处 《World Journal of Hepatology》 CAS 2014年第12期844-850,共7页 世界肝病学杂志(英文版)(电子版)
关键词 PALLIATIVE TRANSCATHETER RADIOFREQUENCY CURATIVE eluting ablation platinum anatomical BEADS OPTION Hepatocellular carcinoma Transcatheter arterial chemoembolization Balloon-occluded transcatheter arterial chemoembolization Drug-eluting bead
  • 相关文献

参考文献9

  • 1Akihiko Seki,Shinich Hori.Switching the Loaded Agent from Epirubicin to Cisplatin: Salvage Transcatheter Arterial Chemoembolization with Drug-eluting Microspheres for Unresectable Hepatocellular Carcinoma[J].CardioVascular and Interventional Radiology.2012(3)
  • 2Takuji Okusaka,Hiroshi Kasugai,Hiroshi Ishii,Masatoshi Kudo,Michio Sata,Katsuaki Tanaka,Yasukazu Shioyama,Kazuaki Chayama,Hiromitsu Kumada,Masaharu Yoshikawa,Toshihito Seki,Hidetugu Saito,Naoaki Hayashi,Keiko Shiratori,Kiwamu Okita,Isao Sakaida,Masao Honda,Yukio Kusumoto,Takuya Tsutsumi,Kenji Sakata.A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma[J].Investigational New Drugs.2012(5)
  • 3Rodolfo Sacco,Irene Bargellini,Marco Bertini,Elena Bozzi,Antonio Romano,Pasquale Petruzzi,Emanuele Tumino,Barbara Ginanni,Graziana Federici,Roberto Cioni,Salvatore Metrangolo,Michele Bertoni,Giampaolo Bresci,Giuseppe Parisi,Emanuele Altomare,Alfonso Capria,Carlo Bartolozzi.Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma[J].Journal of Vascular and Interventional Radiology.2011(11)
  • 4Noboru Maeda,Keigo Osuga,Hiroki Higashihara,Kaname Tomoda,Koji Mikami,Tetsuro Nakazawa,Hironobu Nakamura,Noriyuki Tomiyama.Transarterial Chemoembolization With Cisplatin as Second-Line Treatment for Hepatocellular Carcinoma Unresponsive to Chemoembolization With Epirubicin-Lipiodol Emulsion[J].CardioVascular and Interventional Radiology.2012(1)
  • 5Tomokazu Kawaoka,Hiroshi Aikata,Yoshio Katamura,Shintaro Takaki,Koji Waki,Akira Hiramatsu,Shoichi Takahashi,Masashi Hieda,Hideaki Kakizawa,Kazuaki Chayama.Hypersensitivity Reactions to Transcatheter Chemoembolization with Cisplatin and Lipiodol Suspension for Unresectable Hepatocellular Carcinoma[J].Journal of Vascular and Interventional Radiology.2010(8)
  • 6RenumathyDhanasekaran,David A.Kooby,Charles A.Staley,John S.Kauh,VinitKhanna,Hyun S.Kim.Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)[J].J Surg Oncol.2010(6)
  • 7Shingo Kakeda,Yukunori Korogi,Norihiro Ohnari,Junji Moriya,Nobuhiro Oda,Kazuyoshi Nishino,Wataru Miyamoto.Usefulness of Cone-Beam Volume CT with Flat Panel Detectors in Conjunction with Catheter Angiography for Transcatheter Arterial Embolization[J].Journal of Vascular and Interventional Radiology.2007(12)
  • 8Michael J. Wallace,Ravi Murthy,Paresh P. Kamat,Teri Moore,Sujaya H. Rao,Joe Ensor,Sanjay Gupta,Kamran Ahrar,David C. Madoff,Stephen E. McRae,Marshall E. Hicks.Impact of C-arm CT on Hepatic Arterial Interventions for Hepatic Malignancies[J].Journal of Vascular and Interventional Radiology.2007(12)
  • 9Kenichi Takayasu,Shigeki Arii,Iwao Ikai,Masao Omata,Kiwamu Okita,Takafumi Ichida,Yutaka Matsuyama,Yasuni Nakanuma,Masamichi Kojiro,Masatoshi Makuuchi,Yoshio Yamaoka.Prospective Cohort Study of Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma in 8510 Patients[J].Gastroenterology.2006(2)

同被引文献188

引证文献24

二级引证文献395

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部